Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

NCT04782687 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma
Myeloma Multiple
Kahler Disease
Myeloma, Plasma Cell
Myeloma-Multiple
Myelomatosis
Plasma Cell Myeloma

Interventions

DRUG: Selinexor
DRUG: Dexamethasone Oral
DRUG: Daratumumab
DRUG: Lenalidomide

Sponsor

US Oncology Research

Collaborators

[object Object]